Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Community-based active case-finding interventions for tuberculosis: a systematic review.
BURKE, RM; Nliwasa, M; FEASEY, HR A; Chaisson, LH; Golub, JE; Naufal, F; Shapiro, AE; Ruperez, M; Telisinghe, L; AYLES, H; CORBETT, EL; MacPherson, P;
2021
The Lancet. Public health, (2021).6 5 10.1016/S2468-2667(21)00033-5.
BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial.
PRENTICE, S; Nassanga, B; WEBB, EL; Akello, F; Kiwudhu, F; Akurut, H; ELLIOTT, AM; Arts, RJ W; Netea, MG; DOCKRELL, HM; COSE, S; Delayed BCG Study Team,;
2021
The Lancet. Infectious diseases, (2021).21 7 10.1016/S1473-3099(20)30653-8.
Effect of intermittent preventive treatment for malaria with dihydroartemisinin-piperaquine on immune responses to vaccines among rural Ugandan adolescents: randomised controlled trial protocol B for the 'POPulation differences in VACcine responses' (P...
NATUKUNDA, A; NKURUNUNGI, G; ZIRIMENYA, L; Nassuuna, J; Oduru, G; Amongin, R; Kabuubi, PN; Mutebe, A; Onen, C; Amongi, S; Nakazibwe, E; Akello, F; Kiwanuka, S; Kiwudhu, F; Sewankambo, M; Nsubuga, D; Kizindo, R; STAEDKE, SG; COSE, S; WEBB, E; ELLIOTT, AM; POPVAC trial team,;
2021
BMJ open, (2021).11 2 10.1136/bmjopen-2020-040427.
Antimicrobial resistance and COVID-19: Intersections and implications.
KNIGHT, GM; GLOVER, RE; MCQUAID, CF; OLARU, ID; GALLANDAT, K; LECLERC, QJ; FULLER, NM; WILLCOCKS, SJ; Hasan, R; Van Kleef, E; CHANDLER, CI;
2021
eLife, (2021).10, 10.7554/eLife.64139.
Impact of BCG revaccination on the response to unrelated vaccines in a Ugandan adolescent birth cohort: randomised controlled trial protocol C for the 'POPulation differences in VACcine responses' (POPVAC) programme.
ZIRIMENYA, L; NKURUNUNGI, G; Nassuuna, J; NATUKUNDA, A; Mutebe, A; Oduru, G; Kabami, G; Akurut, H; Onen, C; Namutebi, M; Serubanja, J; Nakazibwe, E; Akello, F; Tumusiime, J; Sewankambo, M; Kiwanuka, S; Kiwudhu, F; Kizindo, R; Kizza, M; WAJJA, A; COSE, S; Muwanga, M; WEBB, E; ELLIOTT, AM; POPVAC trial team,;
2021
BMJ open, (2021).11 2 10.1136/bmjopen-2020-040430.
Effect of intensive treatment for schistosomiasis on immune responses to vaccines among rural Ugandan island adolescents: randomised controlled trial protocol A for the 'POPulation differences in VACcine responses' (POPVAC) programme.
NKURUNUNGI, G; ZIRIMENYA, L; Nassuuna, J; NATUKUNDA, A; Kabuubi, PN; Niwagaba, E; Oduru, G; Kabami, G; Amongin, R; Mutebe, A; Namutebi, M; Zziwa, C; Amongi, S; Ninsiima, C; Onen, C; Akello, F; Sewankambo, M; Kiwanuka, S; Kizindo, R; Kaweesa, J; COSE, S; WEBB, E; ELLIOTT, AM; POPVAC trial team,; POPVAC trial team principal investigator,;
2021
BMJ open, (2021).11 2 10.1136/bmjopen-2020-040426.
Population differences in vaccine responses (POPVAC): scientific rationale and cross-cutting analyses for three linked, randomised controlled trials assessing the role, reversibility and mediators of immunomodulation by chronic infections in the tropics.
NKURUNUNGI, G; ZIRIMENYA, L; NATUKUNDA, A; Nassuuna, J; Oduru, G; Ninsiima, C; Zziwa, C; Akello, F; Kizindo, R; Akello, M; KALEEBU, P; WAJJA, A; Luzze, H; COSE, S; WEBB, E; ELLIOTT, AM; POPVAC trial team,;
2021
BMJ open, (2021).11 2 10.1136/bmjopen-2020-040425.
Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA).
Tanner, R; ZELMER, A; PAINTER, H; Stylianou, E; Pinpathomrat, N; Harrington-Kandt, R; Biffar, L; Brennan, M; McShane, H; FLETCHER, H;
2021
bioRxiv (2021). 10.1101/2021.02.14.431105.
'We had to manage what we had on hand, in whatever way we could': adaptive responses in policy for decentralized drug-resistant tuberculosis care in South Africa.
Kielmann, K; Dickson-Hall, L; Jassat, W; Le Roux, S; Moshabela, M; Cox, H; GRANT, AD; Loveday, M; Hill, J; Nicol, MP; Mlisana, K; Black, J;
2021
Health policy and planning, (2021).36 3 10.1093/heapol/czaa147.
Can what have we learnt about BCG vaccination in the last 20 years help us to design a better tuberculosis vaccine?.
DOCKRELL, HM; BUTKEVICIUTE, E;
2021
Vaccine, (2021).40 11 10.1016/j.vaccine.2021.01.068.